Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2026-06-29 @ 3:14 AM
Study NCT ID:
NCT03884751
Status:
COMPLETED
Last Update Posted:
2022-02-24
First Post:
2019-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chimeric Antigen Receptor T Cells Targeting Glypican-3
Sponsor:
CARsgen Therapeutics Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CT011-HCC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None